// App-Quantinova.ai

3657 : ZBTB7A is a tumor suppressor and novel therapeutic target in triple-negative breast cancer

Researchers

Presenter

  • Mary Ellen Molloy

Principal Investigators

  • Monika Lewinska

  • Xue-Song Liu

  • Angela A. Wang

  • Zhi-Min Yuan

Medical Centers

  • Harvard School of Public Health, Boston, MA

  • Shanghai Tech University, Shanghai, China.

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Tuberculosis

  • Solid malignancies

Biomarkers

  • Lactate Dehydrogenase B

  • Solute Carrier Family 2 Member 3

Drug/Treatment

  • Glutamine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved